Li, Y. (2022). Clinical study of Repatha: it does not affect patients’ cognitive function and significantly reduce blood lipid and prevent coronary atherosclerosis. Highlights in Science, Engineering and Technology, 8, 365-371. https://doi.org/10.54097/hset.v8i.1180